Company Overview
Snapshot
Founded in August 2025 by Yoram Eshel and Chen Brestel, BioAgeMD operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on its R&D product development.
Business overview
BioAgeMD is a digital health startup focused on redefining how human aging is measured and understood. The company's core mission is to make early detection and personalized longevity insights accessible to a broad audience. Operating within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Digital Therapeutics, BioAgeMD aims to serve markets by providing innovative solutions in age management.
Log in to access full profile ›Company Intelligence Q&A
- When was BioAgeMD founded?
- BioAgeMD was founded in August 2025.
- Who are the founders of BioAgeMD?
- BioAgeMD was founded by Yoram Eshel, who serves as Co-founder & CEO, and Chen Brestel, who is the Co-founder & CTO.
- What is BioAgeMD's primary focus?
- BioAgeMD is a digital health startup dedicated to making early detection and personalized longevity insights accessible to everyone, redefining how human aging is measured and understood.
- In which sector does BioAgeMD operate?
- BioAgeMD operates in the Health Tech & Life Sciences sector, with a specific focus on Digital Healthcare and Digital Therapeutics.
- What is the current product stage of BioAgeMD?
- BioAgeMD is currently in the R&D product stage, actively developing its core technology to redefine how human aging is measured and understood, with a mission to make early detection and personalized longevity insights accessible.